Evidence map›Paper›PMID 26621153›Full record

ArticleJournal of cancer research and clinical oncology2016

Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration.

Cornelia Lerner, Silke Wemmert, Florian Bochen, Philipp Kulas, Maximilian Linxweiler, Andrea Hasenfus, Joana Heinzelmann, Petra Leidinger, Christina Backes, Eckart Meese and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. miR-146a-5p Plays an Oncogenic Role in NSCLC via Suppression of TRAF6.Frontiers in cell and developmental biology · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Cornelia LernerDepartment of Otolaryngology, Saarland University Medical Center, Homburg/Saar, Germany. Cornelia.Lerner@uks.eu.
Silke WemmertDepartment of Otolaryngology, Saarland University Medical Center, Homburg/Saar, Germany.
Florian BochenDepartment of Otolaryngology, Saarland University Medical Center, Homburg/Saar, Germany.
Philipp KulasDepartment of Otolaryngology, Saarland University Medical Center, Homburg/Saar, Germany.
Maximilian LinxweilerDepartment of Otolaryngology, Saarland University Medical Center, Homburg/Saar, Germany.
Andrea HasenfusDepartment of Pathology, Saarland University Medical Center, Homburg/Saar, Germany.
Joana HeinzelmannDepartment of Urology and Pediatric Urology, Saarland University Medical Center, Homburg/Saar, Germany.
Petra LeidingerInstitute of Human Genetics, Saarland University, Homburg/Saar, Germany.
Christina BackesInstitute of Human Genetics, Saarland University, Homburg/Saar, Germany.
Eckart MeeseInstitute of Human Genetics, Saarland University, Homburg/Saar, Germany.
Steffi UrbschatDepartment of Neurosurgery, Saarland University Medical Center, Homburg/Saar, Germany.
Bernhard SchickDepartment of Otolaryngology, Saarland University Medical Center, Homburg/Saar, Germany.
Saarland University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHead and neck squamous cell carcinoma (HNSCC) is one of the most common malignancies worldwide with an unchanged 5-year survival rate during the last decade. To detect reliable prognostic markers and improve patients' outcome in future, the aim of our study was to detect differences in microRNA (miRNA; miR) expression profile and further on to analyze the functional role of selected miRNAs.

methodsBlood samples from HNSCC patients and sex- and age-matched healthy volunteers were analyzed by microarrays and validated by quantitative real-time PCR. Data were compared with tumor tissue results and all findings were correlated with clinical parameters. Additionally, the proliferation and migration potential of two cell lines transfected with miRNA mimics and inhibitors for miR-146a and miR-155 were examined.

resultsInitial analysis of blood samples showed no significant differences between the miRNA profile of HNSCC patients and healthy controls (p > 0.05). Interestingly, down-regulation of miR-146a and miR-155 in blood of patients correlated with the occurrence of distant metastasis regarding tumor patients only (p = 0.023 and p = 0.028, respectively). Additionally, our investigations in tissue samples revealed a lower expression of miR-155 in tumor cells (p = 0.003) and a correlation with higher cT-classification for down-regulation of miR-146a (p = 0.005). Moreover, functional assays demonstrated that inhibition of miR-146a and miR-155 promoted dramatically proliferation and migration potential, whereas transfection of both mimics had an inhibitory effect.

conclusionsCharacterizing the expression of miR-146a and miR-155 and their functional role in tumor biology underlined significantly their proliferation and migration potential suggesting relevance as potential prognostic markers in HNSCC.

Indexed as

Cell ProliferationAdultAgedBiomarkers, TumorCarcinoma, Squamous CellCell Line, TumorDown-RegulationFemaleGene Expression Regulation, NeoplasticHead and Neck NeoplasmsHumansMaleMicroRNAsMiddle AgedPredictive Value of TestsPrognosisBiomarkers, TumorMicroRNAsMIRN146 microRNA, humanMIRN155 microRNA, humanBloodHead and neck squamous cell carcinomaMetastasismicroRNA

Identifiers

PMID26621153
PMCPMC11819251
OpenAlexW2259063056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.